多发性硬化症高效疗法对B细胞的影响
Federica Galota1, Simone Marcheselli1, Sara De Biasi2
1Department of Biomedical, Metabolic and Neurosciences, University of Modena and Reggio Emilia, 41121 Modena, Italy.
Cells
|April 25, 2025
概括
早期启动高效疗法治疗可以减少多发性硬化症 (MS) 的长期残疾. 本综述详细介绍了这些疗法如何影响B细胞,影响MS治疗的有效性和安全性.
科学领域:
- 神经免疫学 神经免疫学
- 自身免疫性疾病 自身免疫性疾病
- 中枢神经系统疾病 中枢神经系统疾病
背景情况:
- 多发性硬化症 (MS) 是一种慢性炎症和神经退行性自身免疫性疾病,影响中枢神经系统.
- 虽然传统上被认为是T细胞介导的,但B淋巴细胞在MS的发病过程中发挥着关键作用,有助于炎症和自身活性.
- 使用高效疗法的早期干预对于减轻MS患者的长期残疾至关重要.
研究的目的:
- 审查MS的高效疗法的作用机制.
- 专注于这些疗法对B细胞的影响以及它们对治疗有效性和安全性的贡献.
- 介绍MS的新兴疗法.
主要方法:
- 关于高效性多发性硬化症疗法的现有文献的审查.
- 对作用机制的分析,特别强调B细胞调节.
- 讨论当前和新兴的治疗策略.
主要成果:
- 高效疗法,包括抗CD20单克隆抗体,Alemtuzumab,Cladribine,Natalizumab和S1P受体调节剂,对B细胞群体产生显著影响.
- 向B细胞有助于这些治疗方法在治疗多发性硬化症方面的整体疗效.
- 了解B细胞相互作用是优化安全性概况和开发新疗法的关键.
结论:
- 针对B细胞的高效疗法为治疗多发性硬化症提供了有希望的策略.
- 调节B细胞活性是当前和新兴多发性硬化症治疗的治疗益处和安全性概况的核心.
- 进一步研究针对B细胞的向疗法,如布鲁顿的氨酸激酶抑制剂,是改善MS管理的必要条件.
关键词:
艾伦图祖马布 (Alemtuzumab) 是一种药物.B 细胞 B 细胞 B 细胞克拉德里宾 (cladribine) 是一种药物.娜塔莉莎表示在S1P中,它是S1P.这是一种抗CD2020的药物.疾病修饰疗法 (DMT) 是一种疾病修饰疗法.高效疗法的高效疗法.多发性硬化症多发性硬化症更多相关视频
09:38Determining Immune System Suppression versus CNS Protection for Pharmacological Interventions in Autoimmune Demyelination
Published on: September 12, 2016
12.1K
09:01Flow Cytometric Analysis of Lymphocyte Infiltration in Central Nervous System during Experimental Autoimmune Encephalomyelitis
Published on: November 17, 2020
7.0K
相关概念视频
01:24B Cell Activation and Differentiation
1.2K
The adaptive immune response, a sophisticated defense mechanism, relies on the activation and differentiation of B lymphocytes, or B cells. These processes enable our bodies to mount a tailored response against specific pathogens such as bacteria, free virus particles, toxins, and parasites.
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
When naive B cells encounter a specific antigen that can bind to the B cell receptor (BCR) on their surface, they undergo sensitization to respond to the antigen's presence. Sensitization begins with...
1.2K
01:24T Cell Types and Functions
617
When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...
617